CEIV 2.0 Phase 1: Evaluation
Relevance
Packaging qualification is a critical element of pharmaceutical quality and patient safety, ensuring medicinal products remain protected throughout storage, handling, and distribution. As supply chains become more global and complex, life sciences organisations face growing pressure to accelerate time-to-market, control costs, and improve efficiency while maintaining regulatory compliance. Yet current qualification practices often involve significant duplication of effort, with pharmaceutical companies repeating activities already performed by qualified packaging suppliers, while valuable supplier-generated performance and transport data remains underutilised due to concerns around standardisation, traceability, and regulatory acceptance.
GOAL
Project Objectives
The aim is to obtain the latest industry view on CEIV Pharma and be able to share the recommendations with IATAÂ to raise awareness of the program and engage shippers in the value of CEIV which should aid them in lane assessment, reduction in audit frequency and complexities.
Timeline
June - August
Preliminary Research & Industry Insights
July - September
October
Framework Development & Qualification Mapping
Industry Opinion Paper Publication
PROJECT
SUPPORT AND
COLLABORATION.
- Pharma.Aero Board liaison: Brussels Airport Company and Changi Airport Group
- Project leads: Dnata
- Project members: 38 members respondents to the survey (WP1), +40 Pharma.Aero members and partners involved in the problem-solving sessions organized in collaboration with IATA (WP3)
- Project expert (Phase 1, WP1): Aynur Rasulova-Rzepa, Rzepa Consulting Limited (external consultant)
